Author: Bloom, Patricia P.; Pasricha, Trisha S.; Andersson, Karin L.; Pratt, Daniel S.; Hashemi, Nikroo; Bhan, Irun; Viveiros, Kathleen
Title: Hepatology Consultants Often Disagree on Etiology of Abnormal Liver Biochemistries in COVID-19 but Agree on Management Cord-id: d3z4r0dz Document date: 2020_7_29
ID: d3z4r0dz
Snippet: BACKGROUND: Coronavirus disease 2019 (COVID-19) is associated with elevated liver biochemistries in approximately half of hospitalized patients, with many possible etiologies. AIM: To assess agreement on the etiology of abnormal liver biochemistries and diagnostic recommendations in COVID-19. METHODS: Twenty hepatology consultations were reviewed by three senior hepatologists who provided a differential diagnosis and diagnostic recommendations. Kappa agreement on the primary etiology was calcula
Document: BACKGROUND: Coronavirus disease 2019 (COVID-19) is associated with elevated liver biochemistries in approximately half of hospitalized patients, with many possible etiologies. AIM: To assess agreement on the etiology of abnormal liver biochemistries and diagnostic recommendations in COVID-19. METHODS: Twenty hepatology consultations were reviewed by three senior hepatologists who provided a differential diagnosis and diagnostic recommendations. Kappa agreement on the primary etiology was calculated. RESULTS: Kappa agreement between hepatologists on the primary etiology of elevated liver biochemistries was 0.10 (p = 0.03). Agreement was greater around drug-induced liver injury 0.51 (p < 0.0001) and SARS-CoV-2-related liver injury 0.17 (p = 0.03). Serial liver biochemistries were recommended in all consultations over other evaluations. CONCLUSION: In COVID-19, elevated liver biochemistries present a diagnostic challenge and can often be monitored conservatively.
Search related documents:
Co phrase search for related documents- abdominal imaging and academic institution: 1
- abdominal imaging and liver biopsy: 1
- abdominal imaging and liver disease: 1, 2, 3
- abdominal imaging and liver injury: 1, 2
- abnormal liver and additional testing: 1
- abnormal liver and admission abnormal liver biochemistry: 1
- abnormal liver and liver biochemistry: 1, 2, 3, 4, 5, 6, 7, 8, 9
- abnormal liver and liver biopsy: 1, 2, 3, 4, 5, 6, 7
- abnormal liver and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65
- abnormal liver and liver disease history: 1, 2
- abnormal liver and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- abnormal liver and liver injury pattern: 1, 2, 3
- abnormal liver and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- abnormal liver biochemistry and admission abnormal liver biochemistry: 1
- abnormal liver biochemistry and liver biochemistry: 1, 2, 3, 4, 5, 6, 7
- abnormal liver biochemistry and liver disease: 1, 2, 3, 4, 5
- abnormal liver biochemistry and liver injury: 1, 2, 3, 4
- academic institution and additional testing: 1
- academic institution and liver disease: 1
Co phrase search for related documents, hyperlinks ordered by date